/RMED
RMED Stock - Ra Medical Systems, Inc.
Healthcare|Medical - DevicesAMEX
$0.59+10.00%
+$0.05 (+10.00%) • Aug 17
51
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.0
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.80
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.65
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for RMED
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.59 – $0.60
TARGET (TP)$0.68
STOP LOSS$0.55
RISK/REWARD1:2.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.00
52W High$11.13
52W Low$0.48
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | $420,000 | $14,000 | $22,000 | $4.41M | $7.20M |
| Gross Profit | $378,000 | $-147,000 | $-1,538,000 | $-1,077,000 | $-1,651,000 |
| Gross Margin | 90.0% | -1050.0% | -6990.9% | -24.4% | -22.9% |
| Operating Income | $-11,243,000 | $-26,961,000 | $-29,266,000 | $-36,059,000 | $-57,730,000 |
| Net Income | $-21,801,000 | $-26,865,000 | $-27,261,000 | $-36,045,000 | $-56,957,000 |
| Net Margin | -5190.7% | -191892.9% | -123913.6% | -818.3% | -791.2% |
| EPS | $-6.68 | $-25.98 | $-269.91 | $-1060.77 | $-5416.22 |
Company Overview
Ra Medical Systems, Inc., a medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular immune-mediated inflammatory diseases. It offers destruction of arteriosclerotic blockages by laser radiation ablation, a minimally invasive excimer laser and single-use catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease. The company sells its products primarily through distributors in the United States. Ra Medical Systems, Inc. was incorporated in 2002 and is headquartered in Carlsbad, California.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
RMEDBeat Rate
33%
Last 15 quarters
Avg Surprise
-452.8%
EPS vs Estimate
Beats / Misses
5/10
Last 12 quarters
Latest EPS
$-0.28
Q4 2023
EPS Surprise History
Q1 22
-92.2%
$-61.50vs$-32.00
Q2 22
-58.8%
$-13.50vs$-8.50
Q3 22
+6.3%
$-7.50vs$-8.00
Q4 22
+51.8%
$-3.86vs$-8.00
Q1 23
No data
Q3 23
-3870.6%
$-13.50vs$-0.34
Q3 23
-2400.0%
$-7.50vs$-0.30
Q4 23
+5.6%
$-0.28vs$-0.30
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2024 | May 31, 2024 | — | — | — | — |
Q1 2024 | Mar 26, 2024 | — | — | — | — |
Q4 2023 | Nov 13, 2023 | $-0.30 | $-0.28 | +5.6% | ✓ BEAT |
Q3 2023 | Aug 21, 2023 | $-0.30 | $-7.50 | -2400.0% | ✗ MISS |
Q3 2023 | Jul 3, 2023 | $-0.34 | $-13.50 | -3870.6% | ✗ MISS |
Q1 2023 | Mar 28, 2023 | — | $-3.78 | — | — |
Q4 2022 | Nov 14, 2022 | $-8.00 | $-3.86 | +51.8% | ✓ BEAT |
Q3 2022 | Aug 15, 2022 | $-8.00 | $-7.50 | +6.3% | ✓ BEAT |
Q2 2022 | May 16, 2022 | $-8.50 | $-13.50 | -58.8% | ✗ MISS |
Q1 2022 | Mar 23, 2022 | $-32.00 | $-61.50 | -92.2% | ✗ MISS |
Q4 2021 | Nov 15, 2021 | $-39.50 | $-57.50 | -45.6% | ✗ MISS |
Q3 2021 | Aug 11, 2021 | — | $-88.50 | — | — |
Q2 2021 | May 11, 2021 | $-147.00 | $-124.00 | +15.6% | ✓ BEAT |
Q1 2021 | Mar 16, 2021 | $-125.00 | $-180.50 | -44.4% | ✗ MISS |
Q4 2020 | Nov 12, 2020 | $-150.00 | $-162.50 | -8.3% | ✗ MISS |
Q3 2020 | Aug 11, 2020 | $-212.50 | $-537.50 | -152.9% | ✗ MISS |
Q2 2020 | May 13, 2020 | $-262.50 | $-700.00 | -166.7% | ✗ MISS |
Q1 2020 | Mar 10, 2020 | $-1487.50 | $-900.00 | +39.5% | ✓ BEAT |
Q4 2019 | Nov 29, 2019 | $-950.00 | $-1625.00 | -71.1% | ✗ MISS |
Q2 2019 | Jun 30, 2019 | — | $-1454.04 | — | — |
Latest News
Loading news...
Frequently Asked Questions about RMED
What is RMED's current stock price?
Ra Medical Systems, Inc. (RMED) is currently trading at $0.59 per share. The stock has moved +10.00% today.
What is the analyst price target for RMED?
No analyst price targets are currently available for this stock.
What sector is Ra Medical Systems, Inc. in?
Ra Medical Systems, Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the AMEX exchange.
What is RMED's market cap?
Ra Medical Systems, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does RMED pay dividends?
No, Ra Medical Systems, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBCEL
Atreca, Inc.
$0.09
Mkt Cap: $0.0B
CUTR
Cutera, Inc.
$0.10
Mkt Cap: $0.0B
GRTS
Gritstone bio, Inc.
$0.03
Mkt Cap: $0.0B
HIND
Vyome Holdings, Inc.
$3.68
Mkt Cap: $0.0B
MDGS
Xylo Technologies Ltd.
$2.36
Mkt Cap: $0.0B
NAYA
NAYA Biosciences, Inc.
$2.20
Mkt Cap: $0.0B
PEAR
Pear Therapeutics, Inc.
$0.03
Mkt Cap: $0.0B
VRAY
ViewRay, Inc.
$0.03
Mkt Cap: $0.0B
XYLO
Xylo Technologies Ltd.
$5.07
Mkt Cap: $0.0B
Explore stocks similar to RMED for comparison